Lionville, Pa. January 14, 2008 – West Pharmaceutical Services, Inc. (NYSE: WST), the world’s premier manufacturer of components and systems for injectable drug delivery, today announced a global branding initiative under the name West. The legal entity will remain West Pharmaceutical Services, Inc. and the company will continue to be listed as WST on the New York Stock Exchange.
“For almost 85 years, West has provided best-in-class system and component innovations and have nurtured a high level of reliance and trust,” said Donald E. Morel, Jr. Ph.D., Chairman and Chief Executive Officer. “I am confident the West brand will continue to represent these same values and high standards as we help to improve the safe delivery of pharmaceutical, health care and personal care products.”
The West brand conveys the company’s position as a customer-centered partner to the pharmaceutical, biotechnology and medical technology industries providing a growing range of innovative products and services.
The West brand is accompanied by an updated version of the company’s diamond symbol. The Company is adopting the West brand for all of its global operations.
For additional information about West, please visit www.westpharma.com.
About West
West is the world’s premier manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. West’s customers include the world’s leading pharmaceutical, biotechnology, generic drug and medical device producers. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at http://www.westpharma.com.
